Page last updated: 2024-09-03

23-seleno-25-homotaurocholic acid and Cirrhosis, Liver

23-seleno-25-homotaurocholic acid has been researched along with Cirrhosis, Liver in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
de Caestecker, JS; Jazrawi, RP; Joseph, AE; Maxwell, JD; Nisbett, JA; Northfield, TC1
Chazouillères, O; Haniche, M; Jian, R; Marteau, P; Poupon, R1

Trials

1 trial(s) available for 23-seleno-25-homotaurocholic acid and Cirrhosis, Liver

ArticleYear
Ileal absorption of bile acids in patients with chronic cholestasis: SeHCAT test results and effect of ursodeoxycholic acid (UDCA).
    Digestive diseases and sciences, 1996, Volume: 41, Issue:12

    Topics: Alkaline Phosphatase; Bile Acids and Salts; Cholestasis; Chronic Disease; Down-Regulation; Female; gamma-Glutamyltransferase; Humans; Ileum; Intestinal Absorption; Liver Cirrhosis; Male; Middle Aged; Selenium Radioisotopes; Taurocholic Acid; Up-Regulation; Ursodeoxycholic Acid

1996

Other Studies

1 other study(ies) available for 23-seleno-25-homotaurocholic acid and Cirrhosis, Liver

ArticleYear
Direct assessment of the mechanism for a raised serum bile acid level in chronic liver disease.
    European journal of gastroenterology & hepatology, 1995, Volume: 7, Issue:10

    Topics: Adult; Aged; Aged, 80 and over; Bile Acids and Salts; Female; Humans; Liver; Liver Cirrhosis; Liver Cirrhosis, Biliary; Liver Function Tests; Male; Metabolic Clearance Rate; Middle Aged; Selenium Radioisotopes; Taurocholic Acid

1995